Core Viewpoint - Contineum Therapeutics, Inc. (CTNM) shows significant upside potential with a mean price target of $21.83, indicating a 91.5% increase from the current trading price of $11.4 [1] Price Targets - The average price target consists of six estimates ranging from a low of $14.00 to a high of $29.00, with a standard deviation of $4.79, suggesting variability in analyst predictions [2] - The lowest estimate indicates a potential increase of 22.8%, while the highest suggests a 154.4% upside [2] Analyst Sentiment - Analysts are optimistic about CTNM's earnings prospects, with a consensus indicating better earnings than previously estimated, which historically correlates with stock price increases [4][11] - The Zacks Consensus Estimate for the current year has increased by 1.6% due to one upward revision in estimates over the last 30 days [12] Zacks Rank - CTNM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Price Movement Insights - While consensus price targets may not be entirely reliable, the direction they imply appears to be a useful guide for potential price movements [14]

Group 1 - WeRide Inc. (WRD) shares have increased by 2.7% over the past four weeks, closing at $8.9, with a mean price target of $15 indicating a potential upside of 68.5% [1] - The mean estimate consists of six short-term price targets with a standard deviation of $2.76, where the lowest estimate of $12.00 suggests a 34.8% increase, and the highest estimate of $19.00 indicates a 113.5% surge [2] - Analysts show strong agreement regarding WRD's ability to report better earnings than previously predicted, which supports the expectation of an upside [4][11] Group 2 - The Zacks Consensus Estimate for WRD's current year earnings has increased by 3.4% over the last 30 days, with one estimate moving higher and no negative revisions [12] - WRD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While the consensus price target may not be a reliable indicator of the extent of WRD's gains, it does provide a useful guide for price movement direction [14]

Core Viewpoint - nCino (NCNO) has shown a recent price increase of 6.4% and has a mean price target of $34.73, indicating a potential upside of 32.1% from its current price of $26.29 [1] Price Targets and Analyst Estimates - The mean estimate consists of 15 short-term price targets with a standard deviation of $4.08, suggesting variability in analyst predictions. The lowest estimate is $27.00 (2.7% increase), while the highest is $41.00 (56% increase) [2] - Analysts' price targets can be misleading, as empirical research indicates that they often do not accurately predict stock price movements [7][10] - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts have recently revised their earnings estimates for nCino upward, with a 55.1% increase in the Zacks Consensus Estimate for the current year, reflecting strong optimism about the company's earnings prospects [11][12] - nCino holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, which supports the potential for stock upside [13] Conclusion on Price Movement - While the consensus price target may not be a reliable measure of potential gains, the direction indicated by these targets appears to be a useful guide for investors [14]

Core Viewpoint - OSI Systems (OSIS) has received an upgrade to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on the consensus measure of EPS estimates from sell-side analysts, reflecting the company's changing earnings picture [1][2]. - Changes in future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with near-term stock price movements [4][6]. - Rising earnings estimates for OSI indicate an improvement in the company's underlying business, which is expected to drive the stock price higher [5][10]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7][9]. - The upgrade of OSI to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10]. Earnings Estimate Revisions for OSI - For the fiscal year ending June 2026, OSI is expected to earn $10.42 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 1.9% over the past three months [8].

Group 1 - AvePoint, Inc. (AVPT) shares have increased by 5.2% over the past four weeks, closing at $13.62, with a mean price target of $20 indicating a potential upside of 46.8% [1] - The mean estimate consists of 12 short-term price targets with a standard deviation of $4.07, where the lowest estimate is $16.00 (17.5% increase) and the highest is $28.00 (105.6% increase) [2] - Analysts show strong agreement on AVPT's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has risen by 12% over the past month, with one estimate increasing and no negative revisions [12] - AVPT holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement, which is useful for further research [14]

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Badger Meter (BMI), and highlights the potential misalignment of interests between brokerage firms and retail investors [1][5]. Brokerage Recommendations - Badger Meter has an average brokerage recommendation (ABR) of 1.92, indicating a position between Strong Buy and Buy, based on recommendations from 12 brokerage firms [2]. - Of the 12 recommendations, six are classified as Strong Buy and one as Buy, representing 50% and 8.3% of total recommendations respectively [2]. Limitations of Brokerage Recommendations - Solely relying on brokerage recommendations for investment decisions may not be advisable, as studies suggest they often fail to guide investors effectively towards stocks with high price appreciation potential [5]. - Analysts from brokerage firms tend to exhibit a strong positive bias in their ratings, with five "Strong Buy" recommendations for every "Strong Sell" [6]. Zacks Rank as an Alternative - Zacks Rank, a proprietary stock rating tool, categorizes stocks from Zacks Rank 1 (Strong Buy) to Zacks Rank 5 (Strong Sell) and is considered a more effective indicator of near-term stock performance [8]. - The Zacks Rank is based on earnings estimate revisions, which are strongly correlated with stock price movements, unlike the ABR which may not be timely [12][13]. Current Earnings Estimates for Badger Meter - The Zacks Consensus Estimate for Badger Meter's current year earnings has decreased by 0.1% over the past month to $4.79, reflecting analysts' growing pessimism about the company's earnings prospects [14]. - This decline in consensus estimates has resulted in a Zacks Rank 4 (Sell) for Badger Meter, suggesting caution despite the Buy-equivalent ABR [15].

Core Viewpoint - Amazon (AMZN) shares have increased by 3% over the past four weeks, closing at $227.35, with a mean price target of $295.8 indicating a potential upside of 30.1% according to Wall Street analysts [1]. Price Targets - The average of 54 short-term price targets ranges from a low of $230.00 to a high of $360.00, with a standard deviation of $24.81, suggesting variability in analyst estimates [2]. - The lowest estimate indicates a 1.2% increase from the current price, while the highest estimate suggests a 58.4% upside [2]. Analyst Consensus and Earnings Estimates - Analysts show strong agreement in revising earnings estimates higher, which is a positive indicator for potential stock upside [4][11]. - The Zacks Consensus Estimate for the current year has remained stable, with no negative revisions and one estimate moving higher [12]. - AMZN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set unbiased targets has been questioned [3][10]. - Price targets can often be inflated due to business incentives of firms associated with the stocks [8]. - A low standard deviation in price targets indicates a high degree of agreement among analysts, which can be a starting point for further research [9].

Core Viewpoint - SailPoint, Inc. (SAIL) has seen a 12.9% increase in share price over the past four weeks, closing at $21.02, with analysts suggesting a potential upside to a mean price target of $26.39, indicating a 25.6% increase from the current price [1]. Price Targets and Analyst Consensus - The average price target consists of 21 estimates ranging from a low of $16.00 to a high of $31.70, with a standard deviation of $3.45, indicating variability among analysts [2]. - The lowest estimate suggests a decline of 23.9%, while the highest indicates a potential upside of 50.8% [2]. - Analysts' price targets can be misleading, as empirical research shows they often do not accurately predict stock price movements [7][10]. Earnings Estimates and Analyst Agreement - There is strong agreement among analysts regarding SAIL's ability to report better earnings, which supports the expectation of a stock price increase [4][11]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 7.9%, with five estimates moving higher and no negative revisions [12]. - SAIL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a useful guide for the direction of price movement [14].

Core Viewpoint - Shares of Mama's Creations, Inc. (MAMA) have increased by 35.2% in the past four weeks, closing at $14.06, with a mean price target of $17.6 indicating a potential upside of 25.2% [1] Price Targets - The average price target consists of five estimates ranging from a low of $15.00 to a high of $20.00, with a standard deviation of $2.07, suggesting a potential increase of 6.7% to 42.3% from the current price [2] - A low standard deviation indicates a higher agreement among analysts regarding the price movement of MAMA [2][9] Analyst Sentiment - Analysts have shown increasing optimism about MAMA's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 18.2%, with one estimate moving higher and no negative revisions [12] Zacks Rank - MAMA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of MAMA's potential gains, it does provide a useful guide for the direction of price movement [14]

Core Viewpoint - Theravance Biopharma (TBPH) shares have increased by 1.7% over the past four weeks, closing at $18.79, with a mean price target of $26.71 indicating a potential upside of 42.2% according to Wall Street analysts [1] Price Targets - The average price target consists of seven estimates ranging from a low of $13.00 to a high of $42.00, with a standard deviation of $11.1, indicating variability among analysts [2] - The lowest estimate suggests a decline of 30.8% from the current price, while the highest estimate indicates a potential upside of 123.5% [2] Analyst Sentiment - Analysts are optimistic about TBPH's earnings prospects, as indicated by a trend of upward revisions in earnings estimates, which historically correlates with stock price movements [4][11] - Over the past 30 days, one earnings estimate has increased, leading to a 6.7% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank - TBPH holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of TBPH's potential gains, the implied direction of price movement appears to be a useful guide for investors [14]